Unique ID issued by UMIN | UMIN000001900 |
---|---|
Receipt number | R000002308 |
Scientific Title | PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure |
Date of disclosure of the study information | 2009/04/23 |
Last modified on | 2012/04/23 09:50:55 |
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
PhaseII study of Dasatinib in patients with chronic myeloid leukemia after Imatinib failure
Japan |
Chronic Myeloid Leukemia (chronic phase)
Hematology and clinical oncology |
Malignancy
YES
Efficacy and safety of Dasatinib in Japanese CML patients
Safety,Efficacy
MMR rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
Dasatinib
15 | years-old | <= |
99 | years-old | >= |
Male and Female
Imatinib failure
above 15 years old
PS 0-2
double cancer
pregnancy
etc
60
1st name | |
Middle name | |
Last name | Yoji Ishida |
Iwate Medical Unversity, Internal Medicine
hematology/oncology
Uchimaru19-1,Moriaka,Japan
1st name | |
Middle name | |
Last name |
Iwate Medical University
hematology/oncology
Uchimaru19-1,Morioka,Japan
Inter-Michinoku Dasatinib Study(IMIDAS)
Inter-Michinoku Dasatinib Study(IMIDAS)
Self funding
NO
2009 | Year | 04 | Month | 23 | Day |
Unpublished
Completed
2009 | Year | 02 | Month | 21 | Day |
2009 | Year | 04 | Month | 01 | Day |
2011 | Year | 10 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
2009 | Year | 04 | Month | 23 | Day |
2012 | Year | 04 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002308
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |